-
PEB - Pacific Edge Ltd
Fantasy Premier League 2006/07, 2007/08, and 2008/09 Champion :-)
"The surest sign that intelligent life exists elsewhere in the universe is that none of it has tried to contact us." - C&H
-
Remember BLT?
What were your initial reason for PEB? Do they still hold? Can you afford it? What are the alternatives?
Fantasy Premier League 2006/07, 2007/08, and 2008/09 Champion :-)
"The surest sign that intelligent life exists elsewhere in the universe is that none of it has tried to contact us." - C&H
-
Actually I just mentioned it because I recall my great, great great grand-pappy telling me about him when he had steam-powered wireless
As for BLT - one of my f***-ups but only cost a few grand so no real damage :-( Hopefully someone else will be able to advise you re PEB.
Good luck.
Fantasy Premier League 2006/07, 2007/08, and 2008/09 Champion :-)
"The surest sign that intelligent life exists elsewhere in the universe is that none of it has tried to contact us." - C&H
-
Hancocks I think the prospectous requirements for a nissue to existing shareholders only is a lotless.
-
I'm not a boffin, so this is really just for discussion, but I posted this on the other PEB thread yesterday:
I'm not brave enough to hold this stock, but it really is starting to look quite promising. On the bladder cancer diagnostic, it is worth comparing to Matritech product NPM22 Bladderchek. This is in a strong growth phase and producing revenue of around $US1.8m in the last quarter. The accuracy is not clear, but seems like it may be slightly less than what PEB are claiming. Bladderchek makes up the major part of Matritech revenues and Matritech is currently trading on a Price/Sales ratio of close to 3.5.
PEB are behind in timeline and would need various approvals to get to this point, so probably another 3 years away. But (big assumption) if they could generate similar revenues, and P/S would make the market cap around $36m...
That does not take into account the gastric cancer diagnostic or the possible therapeutics.
However, there is alot of competition in these areas world wide, plus regulatory hurdles and development costs to get through, so the risk is high.
Compared to listed biotech companies working in similar fields, I suspect PEB are very under-valued. In which case the rights issue is a great opportunity to establish a holding very cheaply. New revenue from developments within the next financial year seems very quick too. However, I believe there are alot of companies working on targetted cancer therapeutics and diagnostics and the majority will not end up being the commercial winners. So I would put it at the very high risk end of the investment spectrum and would not be investing money I couldn't afford to lose.
-
At the AGM, did they provide an explaination on why the Annual Report was late?
Death will be reality, Life is just an illusion.
-
Have to say, that after posting here last, I went looking for the Medigen site - the company they are supposed to partnering with. The web-site did not appear to have been updated since early 2004... They did not have any investor info on the site or media releases. It did not appear that they have any commercial products (well at least in early 2004). Now, maybe I've missed something, but it did bother me that if PEB had something, they should be able to find a fairly "strong" company to partner them in it...
Just thought I should post that here to balance out my earlier post...
-
What's Up?
Another one where the old thread is stuck in the snitz forum.
Anyway, what is up with PEB this morning? No action for months and now a steady string of small buyers prepared to pay up. Was there a news article?
-
Member
Lizard mon, a positive report on the business tv this morning mon. Something about they can test for certain types of cancer from a urine test mon.
-
Member
There could be some more good news from PEB in the coming months.They should have their funding in place by the end of the year to carry them through to commercialisation.There may also be some good news regarding the completion of the gastric cancer diagnostic and possibly a licensing agreement.
There was also a positive article in the ODT on 31/8/07 following the AGM.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks